All PlansPrior AuthMedium impact
Mastectomy as a Treatment of Gynecomastia
Regence BlueShield·General Surgery, Plastic Surgery·Prior Authorization
Effective date
Sep 1, 2026
We identified it
Sep 2, 2026
Summary
This new policy establishes prior authorization requirements for mastectomy as treatment of gynecomastia, effective September 1, 2026. Procedures must meet strict medical necessity criteria including Grade II+ gynecomastia with glandular tissue, documented evaluation of reversible causes, breast pain/tenderness, and persistence duration (12+ months for adults, 24+ months for adolescents). Procedures not meeting these criteria are classified as cosmetic and not covered.
Action Required
By August 31, 2026: (1) Billing team must implement prior authorization requirement in billing software for CPT 19300 (Mastectomy for gynecomastia). (2) Providers must be trained to document all required elements before submitting claims: gynecomastia grade (II or higher), tissue type (glandular/fibrotic, not adipose), duration of condition, evaluation of reversible causes (medications reviewed, medical conditions assessed), documentation of breast pain/tenderness, and age-specific persistence duration (12+ months for adults age 19+; 24+ months plus Tanner Stage IV for adolescents 16-18). (3) Update encounter templates and prior auth request forms to include checklist of required documentation. (4) Front desk staff must alert patients that procedures not meeting medical necessity criteria may be classified as cosmetic and subject to patient financial responsibility. (5) Implement claim denial protocols for submissions lacking required documentation or not meeting criteria.